# Clinically Explainable AI for Diabetic Retinopathy Grading

**Author:** Ahsan Bin Hasan Pasha
**Status:** TEMPLATE — insert only genuine MMRDR experiment results.
**Limit:** 2,000 words excluding references.

## 1. Objective and clinical context (~180 words)
Explain the five ordered DR severity categories, decision-support objective and scope as a research prototype, not a validated medical device.

## 2. Methodology (~490 words)
Document the exact source dataset, actual sample counts and class balance, official train/test partitions, training-only stratified validation, image preprocessing and augmentation, ImageNet pretrained ResNet-50, weighted cross-entropy, AdamW, seed, early stopping and chosen macro-F1 criterion. Explicitly note that the official CFP split is image-level, not verified patient-level. Never tune to the test set.

## 3. Results and clinical error analysis (~450 words)
Complete the following table from the held-out test metrics JSON.

| Metric | Observed test value |
| --- | --- |
| Accuracy | [pending] |
| Macro-F1 | [pending] |
| Quadratic-weighted kappa | [pending] |
| Grades 0–4 precision, recall, F1 | [pending] |
| Severe under-grading (2+ grades) | [pending] |

Insert the real confusion matrix. Analyse observed adjacent-grade confusion, grade 3/4 under-calls and overconfident mistakes.

## 4. Reliability and explainability (~360 words)
Use actual reliability diagram, top-label ECE, Brier score and 4–8 real Grad-CAM overlays. Distinguish model attribution from evidence of pathology localisation. Compare selected examples with image-level lesion labels only where supported.

## 5. Anticipated challenge and mitigation (~230 words)
Map to the role's job advert when available. Provisional challenge: trustworthy explanations, severity underestimation, out-of-distribution images. Proposed future mitigation: image-quality gates, review of low-confidence cases, external validation and clinician oversight. Mark untested mitigation as proposed work.

## 6. Limitations and conclusion (~190 words)
Discuss potential patient overlap in image-level split, lack of external-site validation, label variability, calibration risks and lack of proven clinical utility.

## References
1. MMRDR: https://doi.org/10.1038/s41597-026-07005-9
2. DR grading: https://pubmed.ncbi.nlm.nih.gov/13129861/
3. ResNet: https://arxiv.org/abs/1512.03385
4. Grad-CAM: https://doi.org/10.1109/ICCV.2017.74
5. Saliency sanity checks: https://proceedings.neurips.cc/paper/2018/hash/294a8ed24b1ad22ec2e7efea049b8737-Abstract.html
